DANVERS, Mass.--(BUSINESS WIRE)--The Scleroderma Foundation, a national nonprofit that advances medical research, promotes disease awareness and provides support and education to people with ...

The Scleroderma Research Foundation (SRF)—the country’s first and leading nonprofit investor in medical research into scleroderma—announced a $1.5 million dollar matching gift, in the form of a grant ...

In a world where potentially fatal, high-profile diseases like breast cancer and diabetes devour resources and media attention, organizations like the Scleroderma Foundation are necessary to advocate ...

SAN FRANCISCO--(BUSINESS WIRE)--The Scleroderma Research Foundation (SRF), the nation’s largest non-profit funder of scleroderma research, today announced that Sanofi will contribute the first ...

Dedicated to finding a cure for scleroderma, a life-threatening and degenerative illness, by funding and facilitating the most promising, highest quality research and by placing the disease and the ...

Now patients, caregivers and healthcare professionals have an easy and effective way to search and match to scleroderma clinical trials. DANVERS, MA and RALEIGH, NC / ACCESSWIRE / June 14, 2023 / ...

The Scleroderma Research Foundation, the nation’s largest non-profit funder of scleroderma research, announced that the FDA has cleared its Investigational New Drug application to launch the CONQUEST ...

DALLAS, June 21 The Scleroderma Foundation's Texas Bluebonnet Chapter is pleased to announce its third annual Dallas/Fort Worth "Stepping Out to Cure Scleroderma" walk-a-thon to benefit the programs ...

BYFIELD, Mass.--(BUSINESS WIRE)--Jan. 26, 2004--The Scleroderma Foundation awarded $1.45 million in new research grants to 11 recipients. This year’s total funding is the Foundation’s largest ever.

Dr. Gordon will have oversight over the SRF's global clinical trial program CONQUEST and will contribute to the research program across the SRF portfolio "Dr. Gordon, with his impressive track record ...